Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Toll-like receptor 4 and macrophage scavenger receptor 1 crosstalk regulates phagocytosis of a fungal pathogen. | Nat Commun | 2023 | 37580395 | PubTator, text mining | PubMed |
| Novel Fucoidan Pharmaceutical Formulations and Their Potential Application in Oncology-A Review. | Polymers (Basel) | 2023 | 37571136 | PubTator, text mining | PubMed |
| Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome. | Molecules | 2023 | 37570840 | PubTator, text mining | PubMed |
| The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies. | Int J Mol Sci | 2023 | 37569370 | PubTator, text mining | PubMed |
| The Immune Cells in the Development of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37568595 | PubTator, text mining | PubMed |
| Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis. | Front Immunol | 2023 | 37564648 | PubTator, text mining | PubMed |
| Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension. | Commun Biol | 2023 | 37558836 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health. | PLoS One | 2023 | 37556419 | PubTator, text mining | PubMed |
| The Interaction between Macrophages and Triple-negative Breast Cancer Cells Induces ROS-Mediated Interleukin 1α Expression to Enhance Tumorigenesis and Metastasis. | Adv Sci (Weinh) | 2023 | 37551997 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Disturbed lipid profile in common variable immunodeficiency - a pathogenic loop of inflammation and metabolic disturbances. | Front Immunol | 2023 | 37545531 | PubTator, text mining | PubMed |
| Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases. | Front Immunol | 2023 | 37545490 | PubTator, text mining | PubMed |
| Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment. | Am J Physiol Cell Physiol | 2023 | 37545408 | PubTator, text mining | PubMed |
| A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia. | Nat Commun | 2023 | 37542039 | PubTator, text mining | PubMed |
| Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development. | J Hum Genet | 2023 | 37537391 | PubTator, text mining | PubMed |
| Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck. | J Immunother Cancer | 2023 | 37536941 | PubTator, text mining | PubMed |
| The role of mononuclear phagocyte system in IgA nephropathy: pathogenesis and prognosis. | Front Immunol | 2023 | 37529043 | PubTator, text mining | PubMed |
| Kikuchi-Fujimoto disease following COVID-19 in a 32-year-old woman. | J Clin Exp Hematop | 2023 | 37518269 | PubTator, text mining | PubMed |
| Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio. | Medicina (Kaunas) | 2023 | 37512096 | PubTator, text mining | PubMed |
| Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma. | Life (Basel) | 2023 | 37511958 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=20